Publications

6591 POSTER Improved 6-month Survival Rate in Subjects With Prostate Stem Cell Antigen (PSCA) Positive Tumours in a Global, Randomized Phase 2 Trial Comparing Gemcitabine Vs …

BM Wolpin, EM O'Reilly, YJ Ko, MSR Lima, JL Spratlin, T Macarulla, ...

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma

M Lowery, MA Shah, E Smyth, A Epstein, A Segal, O Rosengarten, ...

A woman with remotely treated pancreas cancer and new abdominal pain: A discussion of evaluation and management

AS Epstein, EM O’Reilly, M Lowery, A Shamseddine, J Shia, S Temraz, ...

Abstract C42: Survival signals differentially turn on during TRAIL or curcumin/TRAIL treatment

S Oh, JH Kim, JJ Song, J Kim, HR Yoon, S Kang, W Park, K Hong, SY Kim, ...

Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy

MA Lowery, DS Klimstra, J Shia, KH Yu, PJ Allen, MF Brennan, ...

Adjuvant therapy for pancreas adenocarcinoma: where are we going?

EM O’Reilly

An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions

MA Lowery, DP Kelsen, ZK Stadler, KH Yu, YY Janjigian, E Ludwig, ...

Building on individual, state, and federal initiatives for advance care planning, an integral component of palliative and end-of-life cancer care

AS Epstein, AE Volandes, EM O'Reilly

Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation.

MA Lowery, ZK Stadler, E Ludwig, E Salo-Mullen, DR D'Adamo, PJ Allen, ...

Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium.

C Ang, AP Venook, MA Choti, RP DeMatteo, RK Kelley, D Cosgrove, ...

Costs and trends in pancreatic cancer treatment: A population-based analysis.

CB O'Neill, CL Atoria, EM O'Reilly, J LaFemina, EB Elkin

Does the underlying etiology of HCC effect outcome? A single-institution analysis.

J Ma, M Capanu, EM O'Reilly, NE Kemeny, C Ang, B Gansukh, DP Kelsen, ...

Electronic chemotherapy order entry: A major cancer center's implementation

NT Sklarin, S Granovsky, EM O'Reilly, AD Zelenetz

Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma.

JM Winter, LH Tang, DS Klimstra, MF Brennan, EM O'Reilly, WR Jarnagin, ...

Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor

C Ang, EM O’Reilly, GK Abou-Alfa, A Shamseddine, H Skouri, A Tawil, ...

Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC).

BM Wolpin, EM O'Reilly, Y Ko, LS Blaszkowsky, MU Rarick, ...

Hepatocellular Carcinoma Following Renal Transplantation

C Ang, AK Abu-Alfa, K Abdullah, M Lowery, H Sibai, H El Farran, ...

Improved 6-month survival rate in subjects with prostate stem cell antigen positive tumors in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine+ ags …

M Hidalgo, EM O'Reilly, YJ Ko, LS Blaszkowksy, MU Rarick, CMSR Lima, ...

Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer Achieves High Rate of R0 Resection

KA Goodman, A Wu, A Ho, E O'Reilly, C Winston, D Reidy, P Allen, ...

MicroRNA, hypoxic stress and hepatocellular carcinoma: future directions.

C Ang, EM O'Reilly, GK Abou-Alfa

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

VJ Picozzi, RA Abrams, PA Decker, W Traverso, EM O'reilly, E Greeno, ...

New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy

MA Lowery, EM O’Reilly

Pancreatic cancer: the role of molecular markers in diagnosis and management

MA Lowery, EM O'Reilly

Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC).

EM O'Reilly, WR Jarnagin, MF Brennan, C Winston, LH Tang, M Capanu, ...

Prognostic Value of CA19-9 Level for Locally Advanced Pancreatic Cancer

A Abreu, AY Ho, F Huguet, D Kuk, Z Zhang, EM O'Reilly, KA Goodman

Studying cancer in minorities: a look at the numbers

SH Olson, TM Layne, JA Simon, E Ludwig, E O'Reilly, PJ Allen, RC Kurtz

Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence

DG Power, J Shia, PJ Allen, WR Jarnagin, EM O'Reilly

Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine

GK Abou-Alfa, PB Chapman, J Feilchenfeldt, MF Brennan, M Capanu, ...

Targeting thrombosis in exocrine pancreas cancer: a continued need for improved therapies

AS Epstein, EM O’Reilly

100 questions & answers about pancreatic cancer

E O'Reilly, JF Kelvin

A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)

EM O'reilly, D Niedzwiecki, M Hall, D Hollis, T Bekaii-Saab, T Pluard, ...

A single-institution (MSKCC) analysis of incidence and clinical outcomes in patients with thromboembolic events and exocrine pancreas cancer.

AS Epstein, C Crosbie, S Gardos, GA Soff, MA Shah, DP Kelsen, ...

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

FD Huitzil-Melendez, M Capanu, EM O'Reilly, A Duffy, B Gansukh, ...

Allergies, obesity, other risk factors and survival from pancreatic cancer

SH Olson, JF Chou, E Ludwig, E O'Reilly, PJ Allen, WR Jarnagin, ...

Capsule-induced small-bowel obstruction during video capsule endoscopy in a patient with carcinomatosis

S Nagula, WR Jarnagin, EM O’Reilly, MA Schattner

Clinical outcomes in pancreatic adenocarcinoma (PAC) in breast cancer (BC) survivors.

MA Lowery, ZK Stadler, E Ludwig Miller, DR D'Adamo, E Salo-Mullen, ...

Dx/Rx: Pancreatic Cancer: Pancreatic Cancer

M Lowery, E O'Reilly

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)

HL Kindler, D Niedzwiecki, D Hollis, S Sutherland, D Schrag, H Hurwitz, ...

Hepatocellular carcinoma in two patients with cardiac cirrhosis

T Saliba, S Dorkhom, EM O'Reilly, E Ludwig, B Gansukh, GK Abou-Alfa

Pain and emotional well-being outcomes in Southwest Oncology Group–directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as …

CM Moinpour, NL Vaught, B Goldman, MW Redman, PA Philip, ...

Pancreatic adenocarcinoma: new approaches to a challenging malignancy

MA Lowery, EM O'Reilly

Pancreatic islet cell carcinoma presenting with concurrent Cushing's and Zollinger–Ellison syndromes: case series and literature review

R Said, EM O'Reilly, L Blumgart, J Shia, GK Abou-Alfa

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group–directed intergroup trial …

PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, ...

Refinement of adjuvant therapy for pancreatic cancer

EM O’Reilly

S1985 Pancreatic Cancer Patients From Lynch Syndrome-Like Families Do Not Have Improved Overall Survival When Compared With Sporadic Pancreatic Cancer Patients

E Ludwig, JF Chou, J Simon, EE Salo-Mullen, EM O'Reilly, PJ Allen, ...

Systemic Therapies for Hepatocellular Carcinoma

GK Abou-Alfa, MA Jennifer, EM O’reilly

SYSTEMIC THERAPY AND NOVEL AGENTS IN THE TREATMENT OF PANCREAS CANCER

EM O’REILLY, MA LOWERY, A EPSTEIN, K Ghassan

Targeted Therapies for Hepatocellular Carcinoma

JW Feilchenfeldt, EM O’Reilly, C Albany, GK Abou-Alfa

A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer

RD Carvajal, A Tse, MA Shah, RA Lefkowitz, M Gonen, L Gilman-Rosen, ...

Abstract A71: Studying cancer in minorities: A look at the numbers

TM Layne, SH Olson, J Simon, E Ludwig, E O'Reilly, P Allen, RC Kurtz